Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial. [PDF]
Benítez-Cano A +15 more
europepmc +1 more source
Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China. [PDF]
Qin X +20 more
europepmc +1 more source
Prevalence, Antimicrobial Susceptibility, and Molecular Characteristics of Ceftazidime-Avibactam-Resistant <i>Klebsiella pneumoniae</i> in a Chinese Hospital. [PDF]
Li J +7 more
europepmc +1 more source
Ceftazidime-avibactam for multidrug and pandrug-resistant gram-negative infections in critically Ill children: a single-center pediatric ıntensive care experience. [PDF]
Havan M +11 more
europepmc +1 more source
Combination of Ceftazidime-Avibactam and Meropenem for the Treatment of Pneumonia and Bloodstream Infections Caused by Pan-Drug Resistant <i>Pseudomonas aeruginosa</i> ST244: A Case Report. [PDF]
Kang Y, Kang S, Cui J.
europepmc +1 more source
Stability of Two Reserve Antibiotics in Elastomeric Pumps: Ceftazidime-Avibactam and Ceftolozane-Tazobactam. [PDF]
Erdmann J +3 more
europepmc +1 more source
Tandem amplification of the <i>umpA</i> allele contributes to ceftazidime-avibactam heteroresistance in clinical carbapenem-resistant <i>Klebsiella pneumoniae</i> isolates. [PDF]
Wang M +10 more
europepmc +1 more source
Effectiveness and safety of ceftazidime/avibactam versus polymyxin B in liver transplant recipients with carbapenem-resistant organism infections: a real-world cohort study. [PDF]
Zhang W +6 more
europepmc +1 more source
Is Ceftazidime-Avibactam become a savior for carbapenem-resistant organisms or need something more? [PDF]
Mukhida S, Desai D.
europepmc +1 more source

